Skip to main navigation

Top Menu

JOIN US
CONTACT US

Main Corporate Nav

About Us
The Need
Our Approach
Pipeline
Patients & Families
- Genetic Testing
- Patients and Families
Investors
Join Us
Contact Us

Press Releases

Year

March 14, 2023

Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

February 16, 2023

Decibel Therapeutics to Present at the Upcoming SVB Securities Global Biopharma Conference

February 9, 2023

Decibel Therapeutics to Present at the 46th Annual Association for Research in Otolaryngology (ARO) MidWinter Meeting

January 24, 2023

Decibel Therapeutics Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Lead Gene Therapy Candidate DB-OTO

Shareholder Tools

Contact IR
Contact IR

Email Alerts
Email Alerts

Print Page
Print Page

RSS Feeds
RSS Feeds

Search
Search

© Decibel Therapeutics, Inc. 2023. All rights reserved.

Privacy Notice
Terms of Use

Twitter
LinkedIn

Main Corporate Nav

About Us
The Need
Our Approach
Pipeline
Patients & Families
- Genetic Testing
- Patients and Families
Investors
Join Us
Contact Us